Hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region)
Europe (WHO region): Hypertension effective treatment coverage (controlled hypertension) was 26.1% in 2019. ▲ Rising
Hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region), 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region) stood at 26.1%. That is the highest value across all 30 years on record.
The figure is up 2.4% on the previous year and up 36.6% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region) peaked at 26.1% in 2019 and was at its lowest, 4.6%, in 1990.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 4.6% | — |
| 1991 | 4.8% | +4.3% |
| 1992 | 5.1% | +6.2% |
| 1993 | 5.5% | +7.8% |
| 1994 | 5.9% | +7.3% |
| 1995 | 6.4% | +8.5% |
| 1996 | 7.0% | +9.4% |
| 1997 | 7.6% | +8.6% |
| 1998 | 8.4% | +10.5% |
| 1999 | 9.1% | +8.3% |
| 2000 | 9.9% | +8.8% |
| 2001 | 10.8% | +9.1% |
| 2002 | 11.7% | +8.3% |
| 2003 | 12.7% | +8.5% |
| 2004 | 13.8% | +8.7% |
| 2005 | 14.9% | +8.0% |
| 2006 | 16.0% | +7.4% |
| 2007 | 17.1% | +6.9% |
| 2008 | 18.1% | +5.8% |
| 2009 | 19.1% | +5.5% |
| 2010 | 20.1% | +5.2% |
| 2011 | 21.0% | +4.5% |
| 2012 | 21.8% | +3.8% |
| 2013 | 22.6% | +3.7% |
| 2014 | 23.3% | +3.1% |
| 2015 | 23.9% | +2.6% |
| 2016 | 24.5% | +2.5% |
| 2017 | 25.0% | +2.0% |
| 2018 | 25.5% | +2.0% |
| 2019 | 26.1% | +2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 6.4% | 4.6% | 9.1% | 10 |
| 2000s | 14.4% | 9.9% | 19.1% | 10 |
| 2010s | 23.4% | 20.1% | 26.1% | 10 |
Countries ranked near Europe (WHO region)
More health data for Europe (WHO region)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -33.59 % change on previous year (2025)
- Pertussis - number of reported cases 52,021 (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region)?
- Hypertension effective treatment coverage (controlled hypertension) in Europe (WHO region) was 26.1% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in Europe (WHO region)?
- The highest recorded value was 26.1% in 2019.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in Europe (WHO region)?
- The lowest recorded value was 4.6% in 1990.
- How does Europe (WHO region) rank for hypertension effective treatment coverage (controlled hypertension)?
- Europe (WHO region) ranks 3rd out of 11 groups with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in Europe (WHO region)?
- Over the last ten years it is up 36.6%. The long-run trend across the full record is rising.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).